Chemomab Therapeutics Ltd
NASDAQ:CMMB
Chemomab Therapeutics Ltd
Cash from Investing Activities
Chemomab Therapeutics Ltd
Cash from Investing Activities Peer Comparison
Competitive Cash from Investing Activities Analysis
Latest Figures & CAGR of Competitors
Company | Cash from Investing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Chemomab Therapeutics Ltd
NASDAQ:CMMB
|
Cash from Investing Activities
$15.9m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Collplant Biotechnologies Ltd
NASDAQ:CLGN
|
Cash from Investing Activities
-$1.2m
|
CAGR 3-Years
-31%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
N/A
|
|
Kamada Ltd
NASDAQ:KMDA
|
Cash from Investing Activities
-$5.8m
|
CAGR 3-Years
24%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
-4%
|
|
Urogen Pharma Ltd
NASDAQ:URGN
|
Cash from Investing Activities
-$953k
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Entera Bio Ltd
NASDAQ:ENTX
|
Cash from Investing Activities
-$17k
|
CAGR 3-Years
30%
|
CAGR 5-Years
67%
|
CAGR 10-Years
N/A
|
|
B
|
Bonus Biogroup Ltd
TASE:BONS
|
Cash from Investing Activities
-₪11m
|
CAGR 3-Years
-485%
|
CAGR 5-Years
-100%
|
CAGR 10-Years
-20%
|
See Also
What is Chemomab Therapeutics Ltd's Cash from Investing Activities?
Cash from Investing Activities
15.9m
USD
Based on the financial report for Dec 31, 2023, Chemomab Therapeutics Ltd's Cash from Investing Activities amounts to 15.9m USD.
What is Chemomab Therapeutics Ltd's Cash from Investing Activities growth rate?
Cash from Investing Activities CAGR 1Y
-19%
Over the last year, the Cash from Investing Activities growth was -19%.